TY - JOUR
T1 - Risk factors for recurrence and unfavorable prognosis in patients with stage I non-small cell lung cancer and a tumor diameter of 20 mm or less
AU - Kobayashi, Naruyuki
AU - Toyooka, Shinichi
AU - Sou, Junichi
AU - Ichimura, Kouichi
AU - Yanai, Hiroyuki
AU - Suehisa, Hiroshi
AU - Ichihara, Shuji
AU - Yamane, Masaomi
AU - Aoe, Motoi
AU - Sano, Yoshifumi
AU - Date, Hiroshi
PY - 2007/9
Y1 - 2007/9
N2 - BACKGROUND: The purpose of this study was to identify risk factors for disease recurrence and unfavorable prognosis after surgical resection for stage I non-small cell lung cancer in patients with tumor diameters of ≤20 mm. METHODS: One hundred sixty-three patients who had pathologic stage I non-small cell lung cancer with tumor diameters ≤20 mm and who had undergone a lobectomy with mediastinal lymph node dissection were retrospectively reviewed. The relationships between clinicopathologic factors and clinical outcomes, including recurrence and survival, were then examined. The clinicopathologic factors examined in this study were age, sex, smoking status, preoperative serum carcinoembryonic antigen level, pathologic tumor size, histologic subtype, histologic grade, and visceral pleural invasion. RESULTS: Among the clinicopathologic factors that were examined, the histologic grade of the carcinoma status was significantly related to a high risk of recurrence when analyzed using univariate (p = 0.01) and multivariate analyses (p = 0.049). Regarding survival, patients with poorly differentiated carcinomas showed a significantly unfavorable overall survival (p < 0.001), disease-specific survival (p = 0.003), and disease-free survival (p = 0.002) compared with patients with well-/moderately differentiated carcinomas according to univariate analyses. A Cox proportional hazards model indicated that a poorly differentiated carcinoma status was the only independent factor for an unfavorable overall survival (p = 0.02), disease-specific survival (p = 0.046), and disease-free survival (p = 0.04). CONCLUSIONS: Poor differentiation of tumor was the only risk factor for recurrence and an unfavorable prognosis for stage I non-small cell lung cancer patients with tumor diameters of ≤20 mm.
AB - BACKGROUND: The purpose of this study was to identify risk factors for disease recurrence and unfavorable prognosis after surgical resection for stage I non-small cell lung cancer in patients with tumor diameters of ≤20 mm. METHODS: One hundred sixty-three patients who had pathologic stage I non-small cell lung cancer with tumor diameters ≤20 mm and who had undergone a lobectomy with mediastinal lymph node dissection were retrospectively reviewed. The relationships between clinicopathologic factors and clinical outcomes, including recurrence and survival, were then examined. The clinicopathologic factors examined in this study were age, sex, smoking status, preoperative serum carcinoembryonic antigen level, pathologic tumor size, histologic subtype, histologic grade, and visceral pleural invasion. RESULTS: Among the clinicopathologic factors that were examined, the histologic grade of the carcinoma status was significantly related to a high risk of recurrence when analyzed using univariate (p = 0.01) and multivariate analyses (p = 0.049). Regarding survival, patients with poorly differentiated carcinomas showed a significantly unfavorable overall survival (p < 0.001), disease-specific survival (p = 0.003), and disease-free survival (p = 0.002) compared with patients with well-/moderately differentiated carcinomas according to univariate analyses. A Cox proportional hazards model indicated that a poorly differentiated carcinoma status was the only independent factor for an unfavorable overall survival (p = 0.02), disease-specific survival (p = 0.046), and disease-free survival (p = 0.04). CONCLUSIONS: Poor differentiation of tumor was the only risk factor for recurrence and an unfavorable prognosis for stage I non-small cell lung cancer patients with tumor diameters of ≤20 mm.
KW - Histologic grade
KW - Non-small cell lung cancer
KW - Prognostic factor
KW - Stage I
KW - Tumor diameter of ≤20 mm
UR - http://www.scopus.com/inward/record.url?scp=34548385630&partnerID=8YFLogxK
UR - http://www.scopus.com/inward/citedby.url?scp=34548385630&partnerID=8YFLogxK
U2 - 10.1097/JTO.0b013e31814617c7
DO - 10.1097/JTO.0b013e31814617c7
M3 - Article
C2 - 17805057
AN - SCOPUS:34548385630
SN - 1556-0864
VL - 2
SP - 808
EP - 812
JO - Journal of Thoracic Oncology
JF - Journal of Thoracic Oncology
IS - 9
ER -